secwatch.observer — SEC 8-K summary
======================================

Issuer:     Accelerate Diagnostics, Inc (—)
CIK:        0000727207
Form:       8-K
Filed at:   2023-05-24T23:59:59+00:00
Accession:  0001104659-23-064180
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.07, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Accelerate Diagnostics shareholders approve 250M share increase, reverse split, and equity plan expansion
--------------------------------------------------------------------------------

- Authorized common stock increased from 200M to 450M shares.
- Reverse stock split approved at ratio between 1:5 and 1:30, exact ratio at Board discretion.
- Equity plan share reserve increased by 16M for the 2022 Omnibus Incentive Plan.
- Mark Black elected to Board per Restructuring Support Agreement.
- Nine directors elected; Ernst & Young ratified as auditor for FY2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/727207/000110465923064180/0001104659-23-064180-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/727207/000110465923064180/tm2316472d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-064180

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer